pre-IPO PHARMA

COMPANY OVERVIEW

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to create transformational medicines for patients suffering from infectious diseases. The founding team is uniquely experienced in leveraging strategic partnerships and non-dilutive funding to support global public health programs.


LOCATION

  • Menlo Park, CA, USA

  • THERAPEUTIC AREAS

  • Infectious Disease

  • WEBSITE

    https://www.an2therapeutics.com


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    adjuvant-capital biorock-ventures brii-biosciences mountain-group-partners


    PRESS RELEASES


    Aug 5, 2022

    Thinking about buying stock in AN2 Therapeutics, AMTD IDEA Group, Dynavax Technologies, Yelp, or Honest Company?


    May 9, 2022

    AN2 Therapeutics Appoints Maggie FitzPatrick to Its Board of Directors


    Mar 16, 2022

    AN2 Therapeutics Appoints Dr. Mel Spigelman, M.D. to its Board of Directors


    Feb 16, 2022

    AN2 Therapeutics Announces Epetraborole Granted Orphan Drug Designation in the U.S. for the Treatment of Infections Caused by Non-Tuberculous Mycobacteria


    Feb 10, 2022

    AN2 Therapeutics Reports Phase 1b Data for Oral Epetraborole


    For More Press Releases


    Google Analytics Alternative